Most Recent
NSW government points finger at developer in Opal Tower class action
The NSW government's Sydney Olympic Park Authority, which is facing a class action brought by owners of apartments at the troubled Opal Tower, has laid the blame on the developer, designer and builder behind the project.
Melbourne council may face class action over Prahran Square re-development
The law firm behind multiple government class actions over major construction projects, including the Sydney Light Rail proceeding, is investigating a new case against a Melbourne council after a major development allegedly left local businesses struggling to survive.
University of Sydney wins IP rights case against ObjectiVision
The University of Sydney has emerged triumphant in its long running battle over the intellectual property rights of a glaucoma testing device, with the Federal Court ruling against opthalmic diagnostic tool manufacturer ObjectiVision.
Court signs off on AMP’s new remediation program in ASIC insurance churn case
A judge has given the thumbs up to AMP's new program to identify and compensate victims of so-called insurance churning by its financial planning arm after inadequacies were revealed in the original scheme.
Wyeth loses privilege claim over Allens docs in Merck’s vaccine patent case
Wyeth has lost a bid to claim legal professional privilege over certain documents sought by Merck Sharp & Dohme as the two rivals head towards a hearing for the reopening of the Prevnar 13 patent case.
‘Isn’t that what you’re here for?’: ‘Underbelly’ actor accused of sexual harassment on set of TV series
An Australian actor best known for his role on true crime drama series Underbelly is being sued for sexual harassment after he allegedly grabbed an extra on the set of Bikie Wars and forced his tongue into her mouth without consent.
Concerns ‘poorer’ patients in vaginal mesh class action less likely to be notified of rights
The judge overseeing the Ethicon pelvic mesh class action has flagged serious public policy concerns stemming from class identification problems, amid fears that “poorer” patients in the public health system would be less likely to be notified of their rights compared to those in the private system.
Juno, Millennium settle patent dispute over cancer drug Velcade
Generic drug maker Juno Pharmaceuticals and US-based Millennium Pharmaceuticals have reached an in-principle settlement in their trans-Pacific dispute over two patents covering breakthrough anti-cancer medication Velcade.
Lawyers can advance potential new class action against Scenic Tours over disrupted European cruises
Lawyers pursuing a class action against Scenic Tours on behalf of passengers whose European cruises were interrupted by severe flooding have been granted preliminary discovery as they weigh a second multi-million dollar class action against the company over cancellations caused by last year’s severe drought conditions.
ACCC ‘contaminated’ key evidence in ANZ criminal cartel investigation, court hears
An investigation by the Australian Competition and Consumer Commission has come under fire by the banks and directors targeted in a criminal case over alleged cartel conduct that claim the regulator "contaminated" key evidence and improperly used material supplied by ASIC.